Published on in Vol 9, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16319, first published .
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Jane S Hankins   1 * , MD, MS ;   Nirmish Shah   2 * , MD ;   Lisa DiMartino   3 , PhD, MPH ;   Donald Brambilla   3 , PhD ;   Maria E Fernandez   4 , PhD ;   Robert W Gibson   5 , PhD ;   Victor R Gordeuk   6 , MD ;   Richard Lottenberg   7 , MD ;   Abdullah Kutlar   5 , MD ;   Cathy Melvin   8 , PhD ;   Jena Simon   9 , MS, APRN ;   Ted Wun   10 , MD ;   Marsha Treadwell   11 , PhD ;   Cecelia Calhoun   12 , MD ;   Ana Baumann   12 , PhD ;   Michael B Potter   13 , PhD ;   Lisa Klesges   12 , PhD ;   Hayden Bosworth   2 , PhD ;   Sickle Cell Disease Implementation Consortium   14 *

1 St. Jude Childrens Research Hospital, Memphis, TN, United States

2 Department of Medicine, Duke University, Durham, NC, United States

3 Research Triangle Institute, Research Triangle Park, NC, United States

4 University of Texas Health Science Center at Houston School of Public Health, Houston, TX, United States

5 Center for Blood Disorders, Medical College of Georgia, Augusta University, Augusta, GA, United States

6 Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States

7 Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainsville, FL, United States

8 Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, United States

9 Ichan School of Medicine at Mount Sinai, New York, NY, United States

10 Division of Hematology Oncology, UC Davis School of Medicine, Davis, CA, United States

11 University of California San Francisco Benioff Children Hospital Oakland, Oakland, CA, United States

12 Division of Hematology Oncology, Department of Pediatrics, Washington University, St. Louis, MO, United States

13 University of California San Francisco School of Medicine, San Francisco, CA, United States

14 Bethesda, MA, United States

*these authors contributed equally

Corresponding Author: